Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Hughes, Caryn and Clemens, Graeme and Baker, Matthew J. (2015) Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy. Trends in Biotechnology, 33 (8). pp. 429-430. ISSN 0167-7799

[img]
Preview
 Text (Hughes-etal-TIB-2015-Preclinical-screening-of-anticancer-drugs-using-infrared)
Hughes_etal_TIB_2015_Preclinical_screening_of_anticancer_drugs_using_infrared.pdf
Accepted Author Manuscript
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo
Download (477kB)| Preview

    Abstract

    High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

    Author(s):Hughes, Caryn, Clemens, Graeme and Baker, Matthew J. ORCID logoORCID: https://orcid.org/0000-0003-2362-8581
    Item type:Article
    ID code:55821
    Keywords:cancer, infrared, spectroscopy, high throughput, preclinical screening, biomarker, Pharmacy and materia medica, Chemistry, Neoplasms. Tumors. Oncology (including Cancer), Chemistry(all)
    Subjects:Medicine > Pharmacy and materia medica
    Science > Chemistry
    Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
    Department:Faculty of Science > Pure and Applied Chemistry
    Depositing user: Pure Administrator
    Date deposited:09 Mar 2016 16:23
    Last modified:07 Nov 2019 09:09
    Related URLs:
    URI:https://strathprints.strath.ac.uk/id/eprint/55821
    Export data:
    CORE (COnnecting REpositories)